IDRA - Idera Pharmaceuticals GAAP EPS of -$0.10 August, 09 2022 04:59 PM Idera Pharmaceuticals Inc. Idera Pharmaceuticals press release ( NASDAQ: IDRA ): Q2 GAAP EPS of -$0.10. Shares +4% . Cash position as of June 30, 2022 was $24.5 million For further details see: Idera Pharmaceuticals GAAP EPS of -$0.10